Tenaya Therapeutics, Inc. (TNYA)
0.74
+0.02
(+3.45%)
USD |
NASDAQ |
Apr 14, 09:32
Tenaya Therapeutics Cash from Investing (TTM) : 56.08M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Savara, Inc. | -18.44M |
| Vericel Corp. | -43.94M |
| BioMarin Pharmaceutical, Inc. | -414.24M |